NTCB01-1
Drug3 Days infusion
NCT Number: NCT06625931
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 versus NTCB-P in patients who require parenteral nutrition
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 3
Keimyung University Dongsan Hospital, Daegu, Dalseo-gu, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 Days infusion
3 Days infusion
Time frame: Day 1 to day 4
Yuhan Corporation
Industry
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 Versus NTCB-P in Patients Who Require Parenteral Nutrition
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06737211
Bowel Ischemia, Colonic Diseases
Athens, Greece
View Trial DetailsNCT04816734
Hyperphagia, Parenteral Nutrition
Paris, France
View Trial DetailsNCT06842134
Hyperphagia, Parenteral Nutrition
Austin, Texas, United States
View Trial DetailsNCT06842121
Hyperphagia, Parenteral Nutrition
Austin, Texas, United States
View Trial Details